Amneal completes acquisition of Kashiv BioSciences
Amneal Pharmaceuticals (NASDAQ: AMRX) announced the completion of its acquisition of Kashiv BioSciences, LLC, combining Kashiv's biologics research, development, and ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
